Protocol Ledger

NCT06239727 · Phase III · RECRUITING

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Interventional Phase III clinical trial protocol NCT06239727 sponsored by Sun Yat-sen University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-03-01 Enrollment: 593 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06239727
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)593 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06239727
Protocol FieldVerified Registry Value
NCT IdentifierNCT06239727
Consolidated Lead SponsorSun Yat-sen University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment593 participants (ESTIMATED)
Registered Start Date2024-03-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI